BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26824636)

  • 1. Meta-analysis of diagnostic value of serum Carbohydrate antigen 199 in pancreatic cancer.
    Zhang Y; Jiang L; Song L
    Minerva Med; 2016 Feb; 107(1):62-9. PubMed ID: 26824636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer.
    Li X; Guo X; Li H; Lin H; Sun Y
    Tumour Biol; 2014 Jun; 35(6):5281-6. PubMed ID: 24510349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
    Cui C; Sun X; Zhang J; Han D; Gu J
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of serum macrophage inhibitory cytokine-1 in pancreatic cancer: a meta-analysis and meta-regression analysis.
    Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
    DNA Cell Biol; 2014 Jun; 33(6):370-7. PubMed ID: 24592997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis.
    Su SB; Qin SY; Chen W; Luo W; Jiang HX
    World J Gastroenterol; 2015 Apr; 21(14):4323-33. PubMed ID: 25892884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship of Neutrophil-to-Lymphocyte Ratio or Platelet-to-Lymphocyte Ratio and Pancreatic Cancer in Patients with Type 2 Diabetes.
    Qin S; Lu Y; Chen S; Hu Z; Chen H; Zhong J; Li S; Chen Z
    Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19-9 as a biomarker for diagnosis of pancreatic cancer: A PRISMA-compliant meta-analysis of diagnostic accuracy studies.
    Yang Y; Yan S; Tian H; Bao Y
    Medicine (Baltimore); 2018 Mar; 97(9):e9994. PubMed ID: 29489701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer: a meta-analysis.
    Chen G; Liu S; Zhao Y; Dai M; Zhang T
    Pancreatology; 2013; 13(3):298-304. PubMed ID: 23719604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Carbohydrate Antigen 19-9 in Differential Diagnosis of Benign and Malignant Pancreatic Cystic Neoplasms: A Meta-Analysis.
    Cao S; Hu Y; Gao X; Liao Q; Zhao Y
    PLoS One; 2016; 11(11):e0166406. PubMed ID: 27835676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel blood-based microRNA biomarkers for diagnosis of pancreatic cancer: a meta-analysis.
    Meng QC; Qiu WW; Wen ZQ; Wang HC; Shan ZZ; Yuan Z; Huang XY
    Tumori; 2015; 101(2):199-205. PubMed ID: 25838251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of HE4 in ovarian cancer: A meta-analysis.
    Huang J; Chen J; Huang Q
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():35-42. PubMed ID: 30317143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of S100P for pancreatic cancer: a meta-analysis.
    Hu H; Zhang Q; Huang C; Shen Y; Chen X; Shi X; Tang W
    Tumour Biol; 2014 Oct; 35(10):9479-85. PubMed ID: 25123266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application values of detection of serum CA199, CA242 and CA50 in the diagnosis of pancreatic cancer.
    Lei XF; Jia SZ; Ye J; Qiao YL; Zhao GM; Li XH; Chang H
    J Biol Regul Homeost Agents; 2017; 31(2):383-388. PubMed ID: 28685541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
    Liang B; Zhong L; He Q; Wang S; Pan Z; Wang T; Zhao Y
    Med Sci Monit; 2015 Nov; 21():3555-63. PubMed ID: 26576628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of the diagnostic role of human telomerase activity from pancreatic juice in pancreatic cancer.
    Wang S; Chen X; Tang M
    Tumour Biol; 2014 Aug; 35(8):7897-904. PubMed ID: 24828013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis.
    Gui JC; Yan WL; Liu XD
    Clin Exp Med; 2014 May; 14(2):225-33. PubMed ID: 23456571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA724 is a novel factor for predicting the unresectability in pancreatic adenocarcinoma.
    Liu P; Zhu Y; Liu L
    Int J Clin Exp Pathol; 2015; 8(11):15112-7. PubMed ID: 26823852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic accuracy of HE4 in lung cancer: a meta-analysis.
    Cheng D; Sun Y; He H
    Dis Markers; 2015; 2015():352670. PubMed ID: 25873748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of Serum miR-499a-5p and CA199 Increases the Diagnostic Sensitivity of Pancreatic Cancer.
    Shi Q; Feng K; Xia L; Wang C; Zhu J
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.